Answer
Epoetin alfa may cause a moderate, dose-dependent platelet count rise within the normal range that regresses with continued therapy; thrombocythaemia above the normal range has also been reported, and regular platelet monitoring is recommended during the first 8 weeks.
Sources for this answer
- Eprex 40,000 IU/ml solution for injection in pre-filled syringeJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.4 Special warnings and precautions for use · Version 20Document updated
Sources checked